Category: Press Releases

Dr. Susan S. Margulies Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

Cambridge, MA, July 16, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Susan S. Margulies, Ph.D. has joined the company’s Scientific Advisory Board....

Licensing Agreement Advances Preclinical Therapy for Brain Injuries, Including Concussion

Cambridge, Mass. (May 7, 2015) – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced it has entered into an exclusive worldwide licensing agreement with The University...

Dr. Theodore Liston to Lead Pharmacokinetics and Pharmacodynamics at Astrocyte Pharmaceuticals

Cambridge, Mass., May 1, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Theodore E. Liston, Ph.D. has joined the company as Vice President of Pharmacokinetics...

Former Satori CEO & Pfizer Executive Jeffrey Ives Joins Board of Astrocyte Pharmaceuticals

Cambridge, Mass., December 1, 2014 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Ives, Ph.D. has joined the company’s Board of Directors....

Developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders